Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02946424

Ligand	Ligand name	Chain	PDB	Tanimoto
DPD		A,B	1QIW	0.83
DPD		A	1QIV	0.83
R02	{4-[((1S,2S)-2-{[ALLYL(CYCLOPROPYL)AMINO]METHYL}CYCLOPROPYL)METHOXY]PHENYL}(4-BROMOPHENYL)METHANONE	A,B,C	1H37	0.72
442	2-[3,5-DIBROMO-4-(4-HYDROXY-3-{HYDROXY[(2-PHENYLETHYL)AMINO]METHYL}PHENOXY)PHENYL]ETHANE-1,1-DIOL	A	1R6G	0.81
P14	N-[2-(2-{[(4-{[AMINO(IMINO)METHYL]AMINO}BUTYL)AMINO]METHYL}-4-METHOXYPHENOXY)ETHYL]GUANIDINE	B	1UUD	0.73
C61	(2R,4S,5S,7S)-5-AMINO-N-BUTYL-4-HYDROXY-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-2,8-DIMETHYLNONANAMIDE	C,O	2V10	0.7
HV8	BENZYL-2-AMINO-PARAMETHOXY-BENZYLSTATINE	C	1A8G	0.7
MR1	1-(1,3-BENZODIOXOL-5-YL)METHANAMINE	A	2ORQ	0.72
PZM	1-(4-METHOXYPHENYL)METHANAMINE	A,D,H	2HJB	0.71
RFX	(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	A	3GWV	0.75
REN	(S)-reticuline	A	3FWA	0.74
REN	(S)-reticuline	A	3D2D	0.74
LDT	IDD594	A	1US0	0.75
LDT	IDD594	A	3GHU	0.75
LDT	IDD594	A	3GHT	0.75
LDT	IDD594	A	2I17	0.75
LDT	IDD594	A	2QXW	0.75
LDT	IDD594	A	3GHS	0.75
LDT	IDD594	A	3GHR	0.75
LDT	IDD594	A	2PEV	0.75
LDT	IDD594	A	2I16	0.75
LDT	IDD594	A	2PF8	0.75
LDT	IDD594	A	2PFH	0.75
LDT	IDD594	A	2R24	0.75
SFX	(3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine	A	3GWW	0.75
R71	[4-({6-[ALLYL(METHYL)AMINO]HEXYL}OXY)-2-FLUOROPHENYL](4-BROMOPHENYL)METHANONE	A	1W6J	0.72
R71	[4-({6-[ALLYL(METHYL)AMINO]HEXYL}OXY)-2-FLUOROPHENYL](4-BROMOPHENYL)METHANONE	A,B,C	1GSZ	0.72
5RM	(5R)-5-(4-methoxy-3-propoxyphenyl)-5-methyl-1,3-oxazolidin-2-one	A,B	1XM6	0.73
TAX	(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINIUM	A	1FJ5	0.72
ROL	ROLIPRAM	A,B,C,D	1OYN	0.74
ROL	ROLIPRAM	A,B	1XMY	0.74
ROL	ROLIPRAM	A,B,C,D	1Q9M	0.74
ROL	ROLIPRAM	A,B	1RO6	0.74
ROL	ROLIPRAM	A,B	1XN0	0.74
ROL	ROLIPRAM	A,B	1TBB	0.74
PET	1,5-DI(4-AMIDINOPHENOXY)-3-OXA-PENTANE	B	166D	0.71
Y12	4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE	A	2EW5	0.78
4SR	(4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE	A,B	1XN0	0.74
GNT	(-)-GALANTHAMINE	A	1DX6	0.71
GNT	(-)-GALANTHAMINE	A	1QTI	0.71
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.71
GNT	(-)-GALANTHAMINE	A,B	1W76	0.71
GNT	(-)-GALANTHAMINE	A	1W6R	0.71
TMS	N-PROPYL-4-[(E)-2-(3,4,5-TRIMETHOXY-PHENYL)-VINYL]-BENZAMIDE	A,B	1X6W	0.7
ZD6	4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE	A	2IVU	0.7
F1L	N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	A	2ZJL	0.77
DRR		A,B	3BXR	0.71
P12	4-[AMINO(IMINO)METHYL]-1-[2-(3-AMMONIOPROPOXY)-5-METHOXYBENZYL]PIPERAZIN-1-IUM	B	1UUI	0.73
SNP	1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL	A	1DY4	0.72
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.72
R88	(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE	A,B,C	1H36	0.7
11N	1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine	A,B,C,D	2ZEC	0.71